Mega Matrix Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference, Highlighting Stablecoin Governance Token DAT Strategy
SINGAPORE, Sept. 9, 2025 /PRNewswire/ — Mega Matrix Inc. (“MPU” or the “Company”) (NYSE American: MPU), today announced it will participate... Read more.
Star Refrigeration shortlisted for three honours at the Made in Scotland Awards 2025
GLASGOW, United Kingdom, Sept. 9, 2025 /PRNewswire/ — Star Refrigeration has been recognised for its pioneering role in renewable energy, digital innovation... Read more.
DeuterOncology to Present Promising Phase I DO-2 MET Kinase Inhibitor Data at WCLC 2025
DO-2 is a best-in-class MET kinase inhibitor that has completed enrollment in a Phase 1 dose escalation study Tumor shrinkage was observed in 100% of MET exon 14... Read more.
Kling Bio Validates its Proprietary B-Cell Technology for Rapid Response Against Emerging Viral Variants
Study demonstrated the use of immortalized B-cell libraries as a rapid and adaptable approach to therapeutic development against evolving viral threats Discovered... Read more.
Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman
Dr. Blackman is an Entrepreneur-in-Residence at Google Ventures and a former senior pharma executive with a track record of leading the development of innovative... Read more.
AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial Growth
Funding enables AMSilk to scale industrial production and meet global customer demand for biotech produced silk-based protein materials The financing round was led... Read more.
CONNECTA Therapeutics to Advance CTH120 into Phase II Pediatric Development for Fragile X Syndrome with EIC Accelerator Support
CTH120 is a first-in-class neuroplasticity modulator with strong Phase I safety and tolerability data Awarded a €2.5M European Innovation Council (EIC) Accelerator... Read more.
LUMICKS launches Avidion to improve cell therapy development
Avidion brings clarity to immune drug-tumor interactions, helping scientists identify better cell therapy candidates, understand mechanisms, and advance with confidence.... Read more.
Transparency in Action: CoinEx Confirms 100% Reserve in September 2025
HONG KONG, Sept. 9, 2025 /PRNewswire/ — In the world of cryptocurrency exchanges, Proof of Reserve is one of the most important measures of transparency and... Read more.
MINISFORUM’s AI-Powered N5 Pro Wins AI Storage Technology Innovation Award at IFA 2025
BERLIN, Sept. 9, 2025 /PRNewswire/ — MINISFORUM, a global innovator in compact computing solutions, its AI-powered N5 Pro has been awarded the AI Storage... Read more.